SEC Form 4 · accession 0001209191-16-112581
Inogen Inc · INGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Alison Bauerlein
Officer — EVP, Finance & CFO
Period of report
Mar 31, 2016
Accepted (ET)
Apr 4, 2016 · 7:04 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001294133
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Mar 31, 2016 | S | 3,638 | $44.00 | D | 48,332 | D | |
| Common StockF2 | Mar 31, 2016 | S | 722 | $46.0089 | D | 47,610 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 21, 2015.
- F2Represents the weighted average share price of an aggregate total of 722 shares sold in the price range of $46.00 to $46.06 by the reporting person. The reporting person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.